RYNE BIOTECHNOLOGY INC.

Profile

Company Names

RYNE BIOTECHNOLOGY INC.

Addresses

ONE BROADWAY, 14TH FLOOR KENDALL SQUARE, CAMBRIDGE, MA 02142

Phone Numbers

815-505-6466

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2022

State Incorporated:

DELAWARE

Total Amount Raised:

$33,000,000.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2024-02-26 
$30,000,000.00 
$81,832,753.00 
$51,832,753.00 
Equity 
1
2022-06-13 
$3,000,000.00 
$5,000,000.00 
$2,000,000.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
CARTER 
 
CLIFF 
DIRECTOR
DIANOMI THERAPEUTICS, INC.   |  TACITUS THERAPEUTICS INC.   |  VASCUGEN, INC.   |  RYNE BIOTECHNOLOGY INC.
DAVID 
 
FALLACE 
DIRECTOR
RYNE BIOTECHNOLOGY INC.   |  TASCA THERAPEUTICS CORP
HOWARD 
 
FEDEROFF 
DIRECTOR, EXECUTIVE OFFICER
RYNE BIOTECHNOLOGY INC.
PETER 
 
FUHRKEN 
DIRECTOR
RYNE BIOTECHNOLOGY INC.
JEFF 
 
GOATER 
DIRECTOR
RIBON THERAPEUTICS, INC.   |  RYNE BIOTECHNOLOGY INC.   |  REMIX THERAPEUTICS, INC.   |  NILO THERAPEUTICS, INC.
JEFF 
 
JONAS 
DIRECTOR
ROUNDUP MEDIA, LLC   |  COPEACE PBC   |  GENERATION BIO CO.   |  ANGIOCRINE BIOSCIENCE, INC.   |  RYNE BIOTECHNOLOGY INC.
NICK 
 
MANUSOS 
EXECUTIVE OFFICER, DIRECTOR
RYNE BIOTECHNOLOGY INC.
MARTIN 
 
OSTROWSKI 
EXECUTIVE OFFICER
RYNE BIOTECHNOLOGY INC.
JONATHAN 
 
YEH 
EXECUTIVE OFFICER, DIRECTOR
RYNE BIOTECHNOLOGY INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2024-03-01
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2024-02-26 
2022-07-20
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2022-06-13 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#